Pascal and Francis Bibliographic Databases

Help

Search results

Your search

is.\*:(%220923-7534%22)

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 5920

  • Page / 237
Export

Selection :

  • and

2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-upVANSTEENKISTE, J; CRINO, L; STAHEL, R et al.Annals of oncology. 2014, Vol 25, Num 8, pp 1462-1474, issn 0923-7534, 13 p.Article

A meta-analysis of patient outcomes with subcentimeter disease after chemotherapy for metastatic non-seminomatous germ cell tumorRAVI, P; GRAY, K. P; O'DONNELL, E. K et al.Annals of oncology. 2014, Vol 25, Num 2, pp 331-338, issn 0923-7534, 8 p.Article

A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancerNOVELLO, S; BESSE, B; CARCERENY, E et al.Annals of oncology. 2014, Vol 25, Num 11, pp 2156-2162, issn 0923-7534, 7 p.Article

A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II studySELLE, F; WITTNEBEL, S; CATY, A et al.Annals of oncology. 2014, Vol 25, Num 9, pp 1775-1782, issn 0923-7534, 8 p.Article

A simple technique to estimate best- and worst-case survival in patients with metastatic colorectal cancer treated with chemotherapyWILLIAMS, M; SINGER, R. A; LERNER, A et al.Annals of oncology. 2014, Vol 25, Num 10, pp 2014-2019, issn 0923-7534, 6 p.Article

Activated PI3K/AKT and MAPK pathways are potential good prognostic markers in node-positive, triple-negative breast cancerHASHIMOTO, K; TSUDA, H; KOIZUMI, F et al.Annals of oncology. 2014, Vol 25, Num 10, pp 1973-1979, issn 0923-7534, 7 p.Article

Activity and safety of RAD001 (everolimus) in patients affected by biliary tract cancer progressing after prior chemotherapy: a phase II ITMO studyBUZZONI, R; PUSCEDDU, S; CIARLO, A et al.Annals of oncology. 2014, Vol 25, Num 8, pp 1597-1603, issn 0923-7534, 7 p.Article

Activity of trabectedin in germline BRCA1/2-mutated metastatic breast cancer: results of an international first-in-class phase II studyDELALOGE, S; WOLP-DINIZ, R; LUBINSKI, J et al.Annals of oncology. 2014, Vol 25, Num 6, pp 1152-1158, issn 0923-7534, 7 p.Article

Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01)CHAREHBILI, A; VAN DE VEN, S; PEPELS, M. J et al.Annals of oncology. 2014, Vol 25, Num 5, pp 998-1004, issn 0923-7534, 7 p.Article

Adjuvant cisplatin-based chemotherapy in nonsmall-cell lung cancer: new insights into the effect on failure type via a multistate approachROTOLO, F; DUNANT, A; LE CHEVALIER, T et al.Annals of oncology. 2014, Vol 25, Num 11, pp 2162-2166, issn 0923-7534, 5 p.Article

An update on a systematic review of the use of geriatric assessment for older adults in oncologyPUTS, M. T. E; SANTOS, B; HARDT, J et al.Annals of oncology. 2014, Vol 25, Num 2, pp 307-315, issn 0923-7534, 9 p.Article

Association between treatment toxicity and outcomes in oncology clinical trialsABOLA, M. V; PRASAD, V; JENA, A. B et al.Annals of oncology. 2014, Vol 25, Num 11, pp 2284-2289, issn 0923-7534, 6 p.Article

Association of vegetable and fruit intake with gastric cancer risk among Japanese: a pooled analysis of four cohort studiesSHIMAZU, T; WAKAI, K; SASAZUKI, S et al.Annals of oncology. 2014, Vol 25, Num 6, pp 1228-1233, issn 0923-7534, 6 p.Article

Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agentsMERZ, M; NEBEN, K; GOLDSCHMIDT, H et al.Annals of oncology. 2014, Vol 25, Num 1, pp 189-195, issn 0923-7534, 7 p.Article

Central venous catheter-related infections in hematology and oncology: 2012 updated guidelines on diagnosis, management and prevention by the Infectious Diseases Working Party of the German Society of Hematology and Medical OncologyHENTRICH, M; SCHALK, E; CHRISTOPEIT, M et al.Annals of oncology. 2014, Vol 25, Num 5, pp 936-947, issn 0923-7534, 12 p.Article

Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus controlGLYNNE-JONES, R; COUNSELL, N; QUIRKE, P et al.Annals of oncology. 2014, Vol 25, Num 7, pp 1356-1362, issn 0923-7534, 7 p.Article

Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trialFIZAZI, K; GRAVIS, G; LAPLANCHE, A et al.Annals of oncology. 2014, Vol 25, Num 5, pp 987-991, issn 0923-7534, 5 p.Article

Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumorsDIENSTMANN, R; RODON, J; PRAT, A et al.Annals of oncology. 2014, Vol 25, Num 3, pp 552-563, issn 0923-7534, 12 p.Article

Hodgkin lymphoma after autoimmune diseases by age at diagnosis and histological subtypeFALLAH, M; LIU, X; JI, J et al.Annals of oncology. 2014, Vol 25, Num 7, pp 1397-1404, issn 0923-7534, 8 p.Article

Increased body mass index is associated with improved overall survival in diffuse large B-cell lymphomaWEISS, L; MELCHARDT, T; HABRINGER, S et al.Annals of oncology. 2014, Vol 25, Num 1, pp 171-176, issn 0923-7534, 6 p.Article

Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303)WANEBO, H. J; LEE, J; HANCOCK, M. R et al.Annals of oncology. 2014, Vol 25, Num 10, pp 2036-2041, issn 0923-7534, 6 p.Article

Intensity-modulated radiation therapy leads to survival benefit only in patients with high-risk prostate cancer: a population-based studyGANDAGLIA, G; KARAKIEWICZ, P. I; SUN, M et al.Annals of oncology. 2014, Vol 25, Num 5, pp 979-986, issn 0923-7534, 8 p.Article

Optimal treatment of early-stage ovarian cancerCOLLINSON, F; QIAN, W; FOSSATI, R et al.Annals of oncology. 2014, Vol 25, Num 6, pp 1165-1171, issn 0923-7534, 7 p.Article

Outcome and prognostic factors in patients with mantle-cell lymphoma relapsing after autologous stem-cell transplantation: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT)DIETRICH, S; BOUMENDIL, A; SCHOUTEN, H. C et al.Annals of oncology. 2014, Vol 25, Num 5, pp 1053-1058, issn 0923-7534, 6 p.Article

Pain related to cancer treatments and diagnostic procedures: a no man's land?RIPAMONTI, C. I; BOSSI, P; SANTINI, D et al.Annals of oncology. 2014, Vol 25, Num 6, pp 1097-1106, issn 0923-7534, 10 p.Article

  • Page / 237